Cargando…
Desistance from crime following substance use treatment: the role of treatment retention, social network and self-control
BACKGROUND: Reductions in crime are often reported following substance use treatment. We explore the relationship between desistance from crime, treatment type, treatment retention and positive changes in known risk factors for crime. METHODS: We used data from the NorComt-study; a longitudinal stud...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8588672/ https://www.ncbi.nlm.nih.gov/pubmed/34772369 http://dx.doi.org/10.1186/s12888-021-03518-2 |
_version_ | 1784598527194693632 |
---|---|
author | Skjærvø, Ingeborg Clausen, Thomas Skurtveit, Svetlana Bukten, Anne |
author_facet | Skjærvø, Ingeborg Clausen, Thomas Skurtveit, Svetlana Bukten, Anne |
author_sort | Skjærvø, Ingeborg |
collection | PubMed |
description | BACKGROUND: Reductions in crime are often reported following substance use treatment. We explore the relationship between desistance from crime, treatment type, treatment retention and positive changes in known risk factors for crime. METHODS: We used data from the NorComt-study; a longitudinal study of substance users (n = 341) enrolled in comprehensive treatment in Norway (2012–2015). At treatment initiation (T0) and 1 year later (T1), we collected self-reported data on criminal involvement, treatment, substance use, social network and self-control. We calculated adjusted odds ratios (aOR) and 95% confidence intervals (CI) with multinomial logistic regression analysis. RESULTS: Overall, 1 year following treatment initiation 69% reported desistance from crime, 18% reported continued crime and 12% reported no crime at all in the study period. Desistance was high for OMT patients in ongoing treatment (79% desisted) and for inpatients regardless of treatment status (79–93% desisted), while not as high among OMT patients with interrupted treatment (47% desisted). For participants that continued crime during follow-up, the average number of criminal acts per month was reduced (p < 0.001). Desistance at follow-up was associated with being older (aOR: 1.05, CI: 1.00–1.10), inpatient treatment (aOR: 3.71, CI: 1.12–12.29), being in ongoing treatment (inpatient or OMT) (aOR: 2.90, CI: 1.01–8.36), having no stimulant use in the study period (aOR: 4.86, CI: 1.72–13.70), leaving a substance using social network (aOR 2.87, CI: 1.15–7.18) and improvement in self-control score (aOR: 1.08, CI: 1.04–1.13). CONCLUSIONS: Retention in treatment is particularly important for crime outcomes among OMT patients. Positive changes in social network and self-control are potential contributors to desistance from crime. Targeted interventions towards crime reduction are recommended for patients with stimulant use, which appears to be a persistent risk factor for crime over time. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12888-021-03518-2. |
format | Online Article Text |
id | pubmed-8588672 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-85886722021-11-15 Desistance from crime following substance use treatment: the role of treatment retention, social network and self-control Skjærvø, Ingeborg Clausen, Thomas Skurtveit, Svetlana Bukten, Anne BMC Psychiatry Research Article BACKGROUND: Reductions in crime are often reported following substance use treatment. We explore the relationship between desistance from crime, treatment type, treatment retention and positive changes in known risk factors for crime. METHODS: We used data from the NorComt-study; a longitudinal study of substance users (n = 341) enrolled in comprehensive treatment in Norway (2012–2015). At treatment initiation (T0) and 1 year later (T1), we collected self-reported data on criminal involvement, treatment, substance use, social network and self-control. We calculated adjusted odds ratios (aOR) and 95% confidence intervals (CI) with multinomial logistic regression analysis. RESULTS: Overall, 1 year following treatment initiation 69% reported desistance from crime, 18% reported continued crime and 12% reported no crime at all in the study period. Desistance was high for OMT patients in ongoing treatment (79% desisted) and for inpatients regardless of treatment status (79–93% desisted), while not as high among OMT patients with interrupted treatment (47% desisted). For participants that continued crime during follow-up, the average number of criminal acts per month was reduced (p < 0.001). Desistance at follow-up was associated with being older (aOR: 1.05, CI: 1.00–1.10), inpatient treatment (aOR: 3.71, CI: 1.12–12.29), being in ongoing treatment (inpatient or OMT) (aOR: 2.90, CI: 1.01–8.36), having no stimulant use in the study period (aOR: 4.86, CI: 1.72–13.70), leaving a substance using social network (aOR 2.87, CI: 1.15–7.18) and improvement in self-control score (aOR: 1.08, CI: 1.04–1.13). CONCLUSIONS: Retention in treatment is particularly important for crime outcomes among OMT patients. Positive changes in social network and self-control are potential contributors to desistance from crime. Targeted interventions towards crime reduction are recommended for patients with stimulant use, which appears to be a persistent risk factor for crime over time. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12888-021-03518-2. BioMed Central 2021-11-12 /pmc/articles/PMC8588672/ /pubmed/34772369 http://dx.doi.org/10.1186/s12888-021-03518-2 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Skjærvø, Ingeborg Clausen, Thomas Skurtveit, Svetlana Bukten, Anne Desistance from crime following substance use treatment: the role of treatment retention, social network and self-control |
title | Desistance from crime following substance use treatment: the role of treatment retention, social network and self-control |
title_full | Desistance from crime following substance use treatment: the role of treatment retention, social network and self-control |
title_fullStr | Desistance from crime following substance use treatment: the role of treatment retention, social network and self-control |
title_full_unstemmed | Desistance from crime following substance use treatment: the role of treatment retention, social network and self-control |
title_short | Desistance from crime following substance use treatment: the role of treatment retention, social network and self-control |
title_sort | desistance from crime following substance use treatment: the role of treatment retention, social network and self-control |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8588672/ https://www.ncbi.nlm.nih.gov/pubmed/34772369 http://dx.doi.org/10.1186/s12888-021-03518-2 |
work_keys_str_mv | AT skjærvøingeborg desistancefromcrimefollowingsubstanceusetreatmenttheroleoftreatmentretentionsocialnetworkandselfcontrol AT clausenthomas desistancefromcrimefollowingsubstanceusetreatmenttheroleoftreatmentretentionsocialnetworkandselfcontrol AT skurtveitsvetlana desistancefromcrimefollowingsubstanceusetreatmenttheroleoftreatmentretentionsocialnetworkandselfcontrol AT buktenanne desistancefromcrimefollowingsubstanceusetreatmenttheroleoftreatmentretentionsocialnetworkandselfcontrol |